A polycyclic scaffold identified by structure-based drug design effectively inhibits the human P2X7 receptor

Journal:

Nature Communications

Published:

2025-09-15

DOI:

10.1038/s41467-025-62643-8

Affiliations:

9

Authors:

16

Go to article

Institutions	Authors	Share
University of Barcelona (UB), Spain	3.000000	0.19
National and Kapodistrian University of Athens (UOA), Greece	3.000000	0.19
University of Bonn (Uni Bonn), Germany	3.000000	0.19
Gwangju Institute of Science and Technology (GIST), South Korea	3.000000	0.19
Oregon Health and Science University (OHSU), United States of America (USA)	2.000000	0.13
Ludwig Maximilians University of Munich (LMU), Germany	2.000000	0.13

Interested in Immunology?